• Join Today!

Become a member and connect with:

  • An Active Online Community
  • Articles and Advice on SCD
  • Help Understanding Clinical Trials
scientific articles

The Role of Pain Rehabilitation in an Adolescent Sickle Cell Disease Population: A Case Series

key information

source: Pediatric Hematology and Oncology

year: 2020

authors: Andrew B Collins, Emily A McTate-Acosta, Sara E Williams


Sickle cell disease is an inherited hemoglobinopathy, with relatively high prevalence in African American and some Hispanic populations within the United States. Those with SCD have increased risk for multisystem comorbid conditions as well as shortened lifespan compared to the general population. Pain is the most commonly occurring symptom of SCD, with patients experiencing both acute pain episodes as well as chronic pain that persists beyond exacerbations. Pain accounts for over half of hospital admissions among children with SCD.

While acute pain has historically been a focus of research and clinical care, chronic pain is an increasingly recognized problem in SCD. Diagnostic criteria for chronic pain for patients with SCD is currently defined as pain on more than half of days that is not associated with active disease presence, lasting longer than 6 months. Using these criteria, an estimated 30–40% of adults and adolescents with SCD have chronic pain.

organization: University of Cincinnati College of Medicine, USA; Cincinnati Children's Hospital Medical Center, USA

DOI: 10.1080/08880018.2020.1762811

read more

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.